Chemed Corporation (CHE) is a publicly traded Healthcare sector company. As of July 21, 2026, CHE trades at $501.21 with a market cap of $6.77B and a P/E ratio of 28.10. CHE moved -2.31% today. Year to date, CHE is +19.23%; over the trailing twelve months it is +13.82%. Its 52-week range spans $365.21 to $623.61. Analyst consensus is neutral with an average price target of $473.00. Rallies surfaces CHE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Chemed Corporation (CHE) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CHE moved -2.31% today. Analyst consensus is neutral.
| Metric | Value |
|---|---|
| Price | $501.21 |
| Market Cap | $6.77B |
| P/E Ratio | 28.10 |
| EPS | $18.36 |
| Dividend Yield | 0.60% |
| 52-Week High | $623.61 |
| 52-Week Low | $365.21 |
| Volume | 124.98K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.54B |
| Net Income | $259.78M |
| Gross Margin | 32.38% |
2 analysts cover CHE: 0 strong buy, 0 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $473.00.